Molecular Characteristics of Conjunctival Melanoma Using Whole-Exome Sequencing

Swarup S Swaminathan1, Matthew G Field1,2, David Sant3

  • 1Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida

JAMA Ophthalmology
|November 10, 2017
PubMed
Abstract

Insights

Whole-exome sequencing identified targetable mutations in conjunctival melanoma (CM), a rare ocular cancer. Findings suggest a role for UV light in CM development, warranting further investigation.

Area of Science:

  • Ophthalmology
  • Oncology
  • Genetics

Background:

  • Conjunctival melanoma (CM) is an aggressive ocular cancer with limited treatment options.
  • The molecular underpinnings of CM remain poorly understood.

Purpose of the Study:

  • To elucidate the molecular characteristics of conjunctival melanoma using next-generation whole-exome sequencing (WES).

Main Methods:

  • Whole-exome sequencing (WES) was performed on tumor DNA from 5 CM patients.
  • A customized bioinformatics pipeline was used to analyze samples for driver mutations, copy number aberrations, and mutation signatures.

Main Results:

  • Mutations were identified in oncogenes including BRAF, NRAS, NF1, EGFR, ALK, TERT, and APC.
  • A C→T mutation signature indicative of UV-induced DNA damage was present in all samples.
  • The most frequent copy number aberration was a gain in chromosome 6p.

Conclusions:

  • WES identified targetable mutations and supported the role of UV light in CM pathogenesis.
  • Larger studies are needed to assess the diagnostic, prognostic, and therapeutic potential of WES for CM.